Non-Cochrane · intervention · PM42649488

Efficacy of theracal as pulp capping material in permanent dentition: a systematic review and meta-analysis.

Mohamed Maged Ahmed, Waly Rim, Mahmoud Shahd, et al. · BMC oral health · 2026 · PubMed · doi:10.1186/s12903-026-09008-9

Findings

14 findings

Population
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCBiodentineClinical and/or radiographic success rate
All timepoints combined (overall total in forest plot)
RR 0.97 [0.90, 1.04]
GRADE not reported
3 studies · 564 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCBiodentineClinical and/or radiographic success rate
12 months
RR 0.91 [0.80, 1.04]
67 [-150, 30] per 1000
Moderate
Downgraded: risk of bias
2 studies · 254 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCBiodentineClinical and/or radiographic success rate
6 months
RR 1.00 [0.91, 1.09]
0 [-76, 76] per 1000
Moderate
Downgraded: risk of bias
3 studies · 310 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCcalcium hydroxideClinical and/or radiographic success rate
6 months
RR 1.03 [0.92, 1.16]
-24 [-64, 129] per 1000
Moderate
Downgraded: risk of bias
3 studies · 289 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCcalcium hydroxideClinical and/or radiographic success rate
All timepoints combined (overall total in forest plot)
RR 1.03 [0.94, 1.12]
GRADE not reported
3 studies · 546 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCcalcium hydroxideClinical and/or radiographic success rate
12 months
RR 1.02 [0.88, 1.17]
-15 [-90, 127] per 1000
Moderate
Downgraded: risk of bias
2 studies · 257 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCMTAClinical and/or radiographic success rate
6 months
RR 0.99 [0.91, 1.08]
9 [-77, 68] per 1000
Moderate
Downgraded: risk of bias
3 studies · 312 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCMTAClinical and/or radiographic success rate
12 months
RR 0.88 [0.78, 1.00]
90 [-97, 0] per 1000
Moderate
Downgraded: risk of bias
2 studies · 257 participants
Permanent teeth with vital pulp undergoing direct pulp cappingTheraCal LCMTAClinical and/or radiographic success rate
All timepoints combined (overall total in forest plot)
RR 0.95 [0.89, 1.02]
GRADE not reported
3 studies · 569 participants
Permanent teeth with vital pulp undergoing indirect pulp cappingTheraCal LCcalcium hydroxideClinical and/or radiographic success rate
6 months
RR 1.04 [0.95, 1.15]
-39 [-48, 145] per 1000
Moderate
Downgraded: risk of bias
2 studies · 64 participants
Permanent teeth with vital pulp undergoing indirect pulp cappingTheraCal LCcalcium hydroxideClinical and/or radiographic success rate
12 months
RR 1.02 [0.89, 1.17]
-20 [-108, 167] per 1000
Moderate
Downgraded: risk of bias
2 studies · 98 participants
Permanent teeth with vital pulp undergoing indirect pulp cappingTheraCal LCcalcium hydroxideClinical and/or radiographic success rate
All timepoints combined (overall total in forest plot)
RR 1.00 [0.96, 1.05]
GRADE not reported
3 studies · 200 participants
Permanent teeth with vital pulp undergoing indirect pulp cappingTheraCal LClight-cured calcium hydroxideClinical and/or radiographic success rate
All timepoints combined (overall total in forest plot)
RR 1.06 [0.95, 1.18]
GRADE not reported
2 studies · 82 participants
Permanent teeth with vital pulp undergoing indirect pulp cappingTheraCal LClight-cured calcium hydroxideClinical and/or radiographic success rate
6 months
RR 1.05 [0.93, 1.18]
-48 [-67, 173] per 1000
Moderate
Downgraded: risk of bias
2 studies · 54 participants

Included primary studies 15

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Peskersoy 2020
Efficacy of different calcium silicate materials as pulp-capping agents: Randomized clinical trial.
PMID:33854725
20212 other reviewsnot statednot extracted yet
Awadhesh 2025
Comparative evaluation of four different calcium-based medicaments as an indirect pulp capping agent: An in vivo study.
PMID:41169767
20251 other reviewnot statednot extracted yet
Bayoumy 2021
Clinical and microbiological evaluation of calcium silicate versus calcium hydroxide in two-step indirect pulp treatment: A randomized…
DOI:10.4103/jioh.jioh_33_20
20211 other reviewnot statednot extracted yet
Caliver 2024 (Semprum-Clavier)
Clinical Comparison of Three Indirect Pulp Capping Restorative Protocols: A Randomized Controlled Prospective Study.
PMID:38180467
20241 other reviewnot statednot extracted yet
Iyer 2021
Comparative evaluation of different direct pulp capping agents in carious tooth: An in vivo study.
PMID:35035155
20211 other reviewnot statednot extracted yet
Rahman 2021
Comparative Evaluation of Indirect Pulp Therapy in Young Permanent Teeth using Biodentine and Theracal: A Randomized Clinical Trial.
PMID:34192759
20211 other reviewnot statednot extracted yet
Velioglu 2021
Dört Direkt Pulpa Kapaklama Materyalinin Klinik Takibinin Değerlendirilmesi: Bir Klinik Çalışma
DOI:10.15311/selcukdentj.829044
20211 other reviewnot statednot extracted yet
Abd El-Naby 2023
Randomized Clinical Trial to Compare the Efficacy of Two Calcium Silicate Based Materials in Treatment of Deep Carious Lesion.
DOI:10.21608/ajdsm.2021.110343.1277
2023this review onlynot statednot extracted yet
Caliver 2024
Clinical Comparison of Three Indirect Pulp Capping Restorative Protocols: A Randomized Controlled Prospective Study
DOI:10.2341/22-094-c
2024this review onlynot statednot extracted yet
Cengiz 2015
Efficacy of Erbium, Chromium-doped:Yttrium, Scandium, Gallium, and Garnet Laser Irradiation Combined with Resin-based Tricalcium Silicate…
DOI:10.1016/j.joen.2015.11.015
2016this review onlynot statednot extracted yet
Cengiz 2015
Efficacy of Erbium, Chromium-doped:Yttrium, Scandium, Gallium, and Garnet Laser Irradiation Combined with Resin-based Tricalcium Silicate…
PMID:26723484
2016this review onlynot statednot extracted yet
Deshmukh 2024
Comparative Evaluation of Efficacy of Resin-modified Glass Ionomer Cement and Light-curable Tricalcium Silicate Cement as Indirect Pulp…
DOI:10.5005/jp-journals-10024-3797
2025this review onlynot statednot extracted yet
Deshmukh 2024
Comparative Evaluation of Efficacy of Resin-modified Glass Ionomer Cement and Light-curable Tricalcium Silicate Cement as Indirect Pulp…
PMID:40079993
2024this review onlynot statednot extracted yet
Mahapatra 2022
Comparative Evaluation of the Efficacy of Light-Cured Calcium Hydroxide and a Fourth-Generation Calcium Silicate Cement (TheraCal LC) as…
PMID:36225416
2022this review onlynot statednot extracted yet
Rahman 2021
Comparative Evaluation of Indirect Pulp Therapy in Young Permanent Teeth using Biodentine and Theracal: A Randomized Clinical Trial
DOI:10.17796/1053-4625-45.3.3
2021this review onlynot statednot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationHuman studies involving permanent teeth with vital pulp undergoing direct pulp capping (DPC) or indirect pulp capping (IPC)Permanent teeth with vital pulp, adults mostly aged 15 to 45 years and young permanent teeth; DPC and IPC (n=11 RCTs; 20 to 525 teeth/patients per study)
InterventionTheraCal (TheraCal LC or TheraCal PT) as pulp-capping materialTheraCal LC (n=11)
ComparisonCalcium hydroxide, MTA, Biodentine, resin-modified calcium silicate materials, no treatment, or placeboCalcium hydroxide, light-cured calcium hydroxide, MTA, Biodentine, CEM cement, RMGIC, no liner
OutcomesPrimary: clinical and/or radiographic success rate; secondary: dentin bridge formation, postoperative pain, pulp inflammation or necrosisSuccess rate (pooled); pain and dentin bridge formation (narrative, Supplementary Table S3)
Study designsRandomized controlled trialsRCTs (n=11)
TimingNot specified6 to 36 months follow-up; pooled at 3, 6 and 12 months

AMSTAR 2 items

Two independent extractors rated each item. Their ratings are shown side by side because they have not been reconciled yet. The overall rating follows Shea et al. 2017: one critical flaw gives Low, more than one gives Critically Low.

ItemExtractor AExtractor BAgree
1Research question includes PICO componentsYesYesyes
2Protocol established before the reviewcriticalPartial YesPartial Yesyes
3Choice of study designs explainedNoNoyes
4Comprehensive literature searchcriticalPartial YesPartial Yesyes
5Study selection in duplicateYesYesyes
6Data extraction in duplicateYesYesyes
7List of excluded studies with reasonscriticalYesYesyes
8Included studies described in detailPartial YesPartial Yesyes
9Risk of bias assessed satisfactorilycriticalRCT: YesNRSI: N/A · RCT: Yesno
10Funding of included studies reportedNoNoyes
11Appropriate meta-analysis methodscriticalRCT: YesNRSI: N/A · RCT: Yesno
12Impact of risk of bias on the pooled resultsNoNoyes
13Risk of bias accounted for in interpretationcriticalYesYesyes
14Heterogeneity explainedYesYesyes
15Publication bias investigatedcriticalNoNoyes
16Conflicts of interest reportedYesYesyes
OverallLowLowyes